SocietySouth China Morning Post
US regulator investigates tumour risk in children given Novartis gene therapy
Read the full story at South China Morning Post
The US Food and Drug Administration said on Friday it was investigating a risk of neoplasia, or tumour formation including malignancy, associated with Novartis’ gene therapy Zolgensma.
The Swiss drug maker earlier in the day disclosed two cases in which tumours in children showed evidence of being linked to its gene therapy drug used to treat patients less than two years old with spinal muscular atrophy.
Novartis said that it had received nine reports overall of tumours in patients...
More society
- आज काग तिहार पर्व मनाइँदैNepal Khabar
- चाडपर्वमा देशभर सुरक्षा व्यवस्था कडाNepal Khabar
- तिहार र छठमा बिजुली जान नदिन यस्तो तयारीNepal Khabar
- हेटौँडामा पिकअप र मोटरसाइकल ठोकिँदा युवकको मृत्यु, चालक पक्राउNepal Khabar
- कलाकार रमेश दुलालले यसपालि पनि कागको आवाज निकालेर गरे काग सम्मेलनNepal Khabar
- तिहारका २ दिन उपत्यकाको फोहर व्यवस्थापन नहुने, सडकमा फोहोर नफाल्न महानगरको आग्रहNepal Khabar